315 related articles for article (PubMed ID: 9643392)
1. Treatment of legionnaires' disease.
Klein NC; Cunha BA
Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of legionella pneumonia].
Ewig S; Tuschy P; Fätkenheuer G
Pneumologie; 2002 Nov; 56(11):695-703. PubMed ID: 12442211
[TBL] [Abstract][Full Text] [Related]
3. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
4. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia.
Varner TR; Bookstaver PB; Rudisill CN; Albrecht H
Ann Pharmacother; 2011 Jul; 45(7-8):967-76. PubMed ID: 21775694
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH
Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011
[TBL] [Abstract][Full Text] [Related]
6. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
[No Abstract] [Full Text] [Related]
7. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
8. [Choice of antimicrobial therapy for Legionnella infection].
de Vries PA; van der Werf TS; Manson WL; Zijlstra JG
Ned Tijdschr Geneeskd; 2005 Feb; 149(9):452-7. PubMed ID: 15771338
[TBL] [Abstract][Full Text] [Related]
9. [Pneumonia due to Legionella pneumophila in an immunocompromised child].
van Dijk K; Kamphuis S; Geelen SP; Wulffraat NM; van Gestel JP; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1420-3. PubMed ID: 12174438
[TBL] [Abstract][Full Text] [Related]
10. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Grau S; Antonio JM; Ribes E; Salvadó M; Garcés JM; Garau J
Int J Antimicrob Agents; 2006 Sep; 28(3):249-52. PubMed ID: 16870401
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
Plouffe JF; Breiman RF; Fields BS; Herbert M; Inverso J; Knirsch C; Kolokathis A; Marrie TJ; Nicolle L; Schwartz DB
Clin Infect Dis; 2003 Dec; 37(11):1475-80. PubMed ID: 14614670
[TBL] [Abstract][Full Text] [Related]
12. ["Legionnaires disease"].
Dimitriu S
Rev Med Chir Soc Med Nat Iasi; 1978; 82(3):391-2, 515-6. PubMed ID: 16296493
[No Abstract] [Full Text] [Related]
13. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.
Edelstein PH; Calarco K; Yasui VK
Am Rev Respir Dis; 1984 Nov; 130(5):849-56. PubMed ID: 6333840
[TBL] [Abstract][Full Text] [Related]
14. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A
Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936
[TBL] [Abstract][Full Text] [Related]
15. Legionella: macrolides or quinolones?
Pedro-Botet L; Yu VL
Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for Legionella infection.
Pedro-Botet ML; Yu VL
Expert Opin Pharmacother; 2009 May; 10(7):1109-21. PubMed ID: 19405787
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin and macrolides for treatment of Legionnaires disease: multiple comparisons give few answers.
Kraus CN; Zalkikar J; Powers JH
Clin Infect Dis; 2005 Aug; 41(3):416; author reply 416-7. PubMed ID: 16007549
[No Abstract] [Full Text] [Related]
18. [Legionnaires' disease].
Toyoda K; Saito A
Nihon Rinsho; 1994 Feb; 52(2):384-8. PubMed ID: 8126890
[TBL] [Abstract][Full Text] [Related]
19. [A case of legionnaire's disease due to Legionella pneumophila serogroup 6].
Takamori M; Nakano K; Ubukata H; Suzuki S; Funaki N; Oyama K; Shimada K
Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):1127-9. PubMed ID: 9702025
[No Abstract] [Full Text] [Related]
20. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
